Telesair Inc. raises $22M for hospital-grade respiratory products, home use product in development; led by Pasaca Capital, other investors include Honeywell Ventures.
Telesair Inc., an Irvine-based medical device maker, has raised $22 million in a Series A funding round to support the commercialization of its Bonhawa Respiratory Humidifier and the development of a second-generation product designed to treat patients safely at home. Led by Pasaca Capital, a Pasadena-based venture capital firm, the round also included investments from Honeywell Ventures, ZhenCheng Capital, Shangbay Capital, Device of Tomorrow Capital, Berkeley Catalyst Fund, and Ultrastar Ventures LLC. The company’s co-founders, Bryan Liu, Tyler Li, and Don Lin, have extensive experience in the medical device industry.
Telesair is focused on developing “hospital-level respiratory care in the home” to reduce the need for hospital stays and increase accessibility for those who need oxygen assistance. The company has been in “stealth mode” to develop their products and recently announced a license agreement with a “leading global medical device manufacturer” to develop a new respiratory platform. The agreement includes an upfront payment, milestone payment upon completion of the offering, and ongoing royalty payments based on sales of the device.
Respiratory diseases are on the rise, and Telesair is one of many Orange County-based companies focused on developing respiratory devices. The company’s website notes that 545 million people suffer from chronic obstructive pulmonary disease, which is the third leading cause of death worldwide. Telesair’s mission is to increase accessibility for all people who need oxygen assistance with their proprietary solutions.
Telesair’s Series A funding will be used to commercialize their existing product and develop a new product for use at home. The company has 20 employees and plans to hire another 20 this year. With the help of their experienced team and the funding from investors, Telesair is well-positioned to make a difference in the lives of those who need respiratory assistance.